---

Exhibit 99.11

September 29, 2020

Rexahn Pharmaceuticals, Inc.

15245 Shady Grove Road, Suite 455

Rockville, MD 20850

Consent to Reference in Proxy Statement/Prospectus/Information Statement

Rexahn Pharmaceuticals, Inc. (the “Company”) has filed the Registration Statement on Form S-4 (Registration No. 333- 239702), as amended, with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such registration statement as a future member of the board of directors of the Company.

---